Injectable Drug Delivery
May 8-9, London, UK
Request a Meeting
ApiJect is Making Prefilled Drug Delivery Possible for More Injectables than Ever Before
EXPANDED MARKET ACCESS
ApiJect’s advancements in Blow-Fill-Seal (BFS) aseptic packaging enhance cost-effectiveness and reliability in fill-finish processes for sterile liquids and pave the way for injectables to reach more patients in various markets through a prefilled, ready-to-use format.
SUSTAINABILITY
ApiJect devices are designed with less plastic than a standard syringe and avoids high energy and high carbon footprint manufacturing processes associated with glass vials and prefilled syringes
.gif?width=644&height=364&name=BoPFSPrefilled%20(1).gif "BoPFSPrefilled (1)")
PREFILLED FORMAT AT SINGLE VIAL COST
At ApiJect, we combine the manufacturing technologies of BFS and injection molding to enable drugs and vaccines to be fill-finished in a prefilled injectable format at any scale and at a lower total cost of dose delivery.
Note: The Prefilled ApiJect Injector and its components are not cleared by the FDA or other regulatory bodies.
Morgan Amsler
Director | Business Development
“Innovations in Drug Delivery: Expanding Access with a Prefilled, Plastic Solution”
Wednesday, May 8, 2024 | 2:00pm EST
Key Takeaways
- Examine the supply chain and delivery challenges that limit access to injectable therapeutics.
- Discuss the strategies to expand access to injectables using existing and new technologies.
- Review how the pharmaceutical industry will transition to plastic, prefilled delivery solutions.
The Prefilled ApiJect Injector* is the combination of two trusted technologies: BFS aseptic drug packaging process, and a pen needle-style needle hub.
Our approach is just one example of how we are creating prefilled injectors that work for everyone in all markets… that are easy to use, cost effective, and more environmentally friendly.
ApiJect has product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS) using ApiJect prefilled injector technology. Higher volumes may be needed based on the specific requirements of the drug product.
